Follow The Filings

TELA TELA Bio

TELA Bio earnings company data as of 4:48 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 12 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by TELA's executives, directors and 10% owners in the last 12 months, from their Form 4s

All TELA insider trades
  • $4.2M bought by 3 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Joseph H Capper Director
    Buy
    $89K 75,000 shares at $1.18 +72% to stake
    Traded Sep 16–17 Filed Sep 18
  2. Joseph H Capper Director
    Buy
    $78K 75,000 shares at $1.05 +252% to stake
    Traded Sep 14–15 Filed Sep 16
  3. Heather C Getz CEO
    Buy
    $8,311 12,500 shares at $0.6600 +2.4% to stake
    Traded Aug 17 Filed Aug 19
  4. Heather C Getz CEO
    Buy
    $10K 15,000 shares at $0.7000 +3% to stake
    Traded Aug 14 Filed Aug 17
  5. Ew Healthcare Partners Fund 2, L.P. 10% owner, +3 joint filers
    Buy
    $4M 3,604,000 shares at $1.11 +88% to stake
    Traded Nov 17, 2025 Filed Nov 17, 2025

Also filed in the last 12 months, not counted as buying or selling: 22 stock grants and 12 share withholdings for taxes.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K 5.07
8-K 8.01
8-K 8.01,9.01
8-K 1.01
8-K 3.01
DEF 14A
8-K 2.05,5.02,7.01,9.01
SCHEDULE 13G/A —
SCHEDULE 13G/A —
8-K/A 5.02
SCHEDULE 13G —
10-Q
8-K 2.02,9.01
8-K 5.02
8-K 5.02,5.07,9.01
SCHEDULE 13D —
SCHEDULE 13G/A —
10-Q
8-K 2.02,7.01,9.01
DEF 14A
8-K 2.02,5.02
DEFA14A
10-K
8-K 2.02,7.01,9.01
8-K 3.01

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.